J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight

By Dorothy Atkins · May 1, 2024, 5:40 PM EDT

A New Jersey federal judge has signed off on a consent judgment that permanently bars Chinese drugmaker Jiangsu Hengrui Pharmaceuticals Co. from misappropriating Johnson and Johnson's pharmaceutical subsidiary Janssen's trade secrets...

To view the full article, register now.